Posted inGenetics
Building a Bioprocess for a Cancer-Fighting Biosimilar
In the next few years, atezolizumab will go off patent in the United States and Europe. This monoclonal antibody is…
Posted inGenetics
Illumina, Nvidia Launch AI-Based Genomics Partnership
SAN FRANCISCO—Nvidia will partner with Illumina to apply genomics and AI technologies to analyze and interpret multi-omic data in drug…
Posted inGenetics
Nanoscopy Unravels the Interplay Between Antibodies and CD20 in Immunotherapy
Therapeutic monoclonal antibodies (mAbs) are used in chronic lymphocytic leukemia immunotherapies to target the receptor CD20 at the plasma membrane…
Posted inGenetics
The Juice from J.P. Morgan: Takeaways from San Francisco
Broadcast Date: Tuesday, January 21, 2025Time: 9:00 am PT, 12:00 pm ET, 18:00 CET The new year doesn’t start for…
Posted inGenetics
Potential New Retinitis Pigmentosa Candidates Found in Compounds That Stabilize Rhodopsin Structure
Scientists have identified two non-retinoid compounds that may be able to treat retinitis pigmentosa (RP), a group of inherited eye…
Posted inGenetics
Mutation Mechanism Found That Drives the Aggressive Development and Evolution of Osteosarcoma
Researchers published a new study, “Ongoing chromothripsis underpins osteosarcoma genome complexity and clonal evolution,” in Cell that they say solves…
Posted inGenetics
Zika Virus Hijacks Protein Important to Brain Development, to Support Viral Replication
Zika virus (ZIKV) is a mosquito-borne orthoflavivirus that can cause birth defects, including microcephaly, a condition in which head and…
Posted inGenetics
Genetic Analysis Reveals Bacterium’s Survival Tactics
Staphylococcus aureus (S. aureus) is a common type of bacterium that is usually harmless to many people, but for others…
Posted inGenetics
J&J to Acquire Intra-Cellular for $14.6B
Johnson & Johnson has agreed to acquire Intra-Cellular Therapies for approximately $14.6 billion, the companies said today, in the largest…
Posted inGenetics
Iconovo and Lonza Agree to Collaborate on the Formulation Development of an Intranasal Biologic
Iconovo, which develops inhalable drugs based on proprietary inhalers and dry powder formulations, reports that it and Lonza initiated a…